The IRE website will be unavailable while we complete routine maintenance on Friday, April 16 from 8-10 am CT.
IRE favicon

Shop

Resource ID: #19320
Subject: Pharmaceuticals
Source: New York Times
Affiliation: 
Date: 23-Jul-00

Description

The New York Times examined court records and other public documents in Washington and other states and interviewed regulators and drug company executives with a particular focus on Hytrin. The review showed how efforts to extend a profitable drub's monopoly, as much as the pursuit of scientific discoveries, drive decisions in one of the world's most lucrative, and secretive, industries.

This file is not available for digital download. IRE members may place an order by emailing rescntr@ire.org

141 Neff Annex   |   Missouri School of Journalism Columbia, MO 65211   |   573-882-2042   |   info@ire.org   |   Privacy Policy
apartmentpenciluserscalendar-fullcrossmenuwarning linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram